ANAVEX LIFE SCIENCES CORP. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $130.00 thousand for the 12-month period ending 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $130.00K.
- ANAVEX LIFE SCIENCES CORP. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was -$276.00K, a 201.10% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $273.00K.
- ANAVEX LIFE SCIENCES CORP. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $741.00K, a 2017.14% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-09-30 | $130.00K 10-K/A · filed 2026-08-28 | |
| 2024-09-30 | -$276.00K 10-K/A · filed 2026-08-28 | |
| 2023-09-30 | $273.00K 10-K/A · filed 2026-08-28 | |
| 2021-09-30 | $741.00K 10-K · filed 2023-11-27 | |
| 2020-09-30 | $35.00K 10-K · filed 2022-11-28 | |
| 2019-09-30 | $140.00K 10-K · filed 2020-12-28 | |
| 2018-09-30 | $131.00K 10-K · filed 2019-12-16 | $1.00K 10-K · filed 2018-12-12 |
| 2017-09-30 | $2.00K 10-K · filed 2019-01-25 | |
| 2015-09-30 | -$5.00K 10-K · filed 2017-12-11 | |
| 2014-09-30 | -$16.00K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |